Jeil Pharmaceutical Co Ltd (271980) — Long-term Investment Intensity

Latest as of September 2019: 0.2%

Jeil Pharmaceutical Co Ltd (271980) has a Long-term Investment Intensity of 0.2% as of September 2019. Long-term investments of ₩962.66 Million represent 0.2% of total assets of ₩401.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Jeil Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

₩962.66 Million
KRW

Total Assets

₩401.59 Billion
KRW

Country

Korea
KO

Jeil Pharmaceutical Co Ltd Long-term Investment Intensity (2017–2018)

This chart shows how Jeil Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 0.2%, reflecting long-term investments of ₩962.66 Million against total assets of ₩401.59 Billion KRW. For the complete balance sheet picture, see Jeil Pharmaceutical Co Ltd asset portfolio.

Annual Long-term Investment Intensity for Jeil Pharmaceutical Co Ltd (2017–2018)

The table below presents the year-by-year Long-term Investment Intensity for Jeil Pharmaceutical Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 271980 current and long-term liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 0.2% ₩977.95 Million ₩402.90 Billion ▼ -0.5 pp
2017 0.7% ₩3.03 Billion ₩413.73 Billion
pp = percentage points